SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-049786
Filing Date
2021-09-24
Accepted
2021-09-24 16:07:37
Documents
15
Period of Report
2021-09-24
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea147907-8k_inmedpharm.htm   iXBRL 8-K 38999
2 NEWS RELEASE, DATED SEPTEMBER 24, 2021 ea147907ex99-1_inmedpharma.htm EX-99.1 96377
7 GRAPHIC ex99-1_001.jpg GRAPHIC 18286
  Complete submission text file 0001213900-21-049786.txt   388357

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE inm-20210924.xsd EX-101.SCH 3268
4 XBRL DEFINITION FILE inm-20210924_def.xml EX-101.DEF 26195
5 XBRL LABEL FILE inm-20210924_lab.xml EX-101.LAB 35952
6 XBRL PRESENTATION FILE inm-20210924_pre.xml EX-101.PRE 24853
8 EXTRACTED XBRL INSTANCE DOCUMENT ea147907-8k_inmedpharm_htm.xml XML 4316
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 211277332
SIC: 2834 Pharmaceutical Preparations